Skip to content
  • Add anything here or just remove it...
ImpentriImpentri
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

Lookbook

Lookbook Summer

Lookbook

Flat T-Shirt Company

Lookbook

  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005142.

This Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.

IMPENTRI IMI2Follow

IMPENTRI IMI2
Imi2Impentri
28 Jun

catch our colleague, Dr Imke Bartelink presenting this morning at the #EACPT2022 on “Pharmacokinetics and Pharmacodynamics for Optimal Drug Repurposing of Imatinib from Cancer to COVID-19”

Reply on Twitter 1541688176728842241Retweet on Twitter 1541688176728842241Like on Twitter 15416881767288422412Twitter 1541688176728842241
Imi2Impentri
21 Jun

Have a look at @InnoRadarEU's page for the #EUfunded #innovation: 'Evaluation of the safety and efficacy of intravenous imatinib (Impentri™) for the treatment of patients with moderate to severe Acute Respiratory Distress Syndrome, caused by COVID'. https://www.innoradar.eu/innovation/41910

Reply on Twitter 1539212189696933891Retweet on Twitter 1539212189696933891Like on Twitter 15392121896969338912Twitter 1539212189696933891
Imi2Impentri
18 May

Check out the presentations this morning, from the clinical teams from AMC and VUmc, Amsterdam, who are presenting their results of the clinical trial of oral imatinib for the treatment of hospitalized COVID-19 patients. #ATS2022

Reply on Twitter 1526934267179180032Retweet on Twitter 1526934267179180032Like on Twitter 15269342671791800321Twitter 1526934267179180032
Load More...
Copyright 2022 © Exvastat Ltd
  • Home
  • About
  • Imatinib for COVID-19
  • News
  • Exvastat
  • Contact
    • WooCommerce not Found